David J Heal Selected Research

Narcotic Antagonists (Opioid Antagonists)

1/2017

Dopamine and μ-opioid receptor dysregulation in the brains of binge-eating female rats - possible relevance in the psychopathology and treatment of binge-eating disorder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Heal Research Topics

Disease

12	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2024 - 01/2006
5	Obesity 01/2022 - 03/2004
4	Binge-Eating Disorder (Binge Eating Disorder) 01/2024 - 01/2016
4	Substance-Related Disorders (Drug Abuse) 01/2023 - 01/2019
4	Bulimia (Binge Eating) 01/2017 - 12/2015
3	Mental Disorders (Mental Disorder) 01/2024 - 11/2018
3	Schizophrenia (Dementia Praecox) 01/2022 - 01/2012
2	Parkinson Disease (Parkinson's Disease) 01/2019 - 09/2012
2	Glucose Intolerance 03/2012 - 01/2012
1	Nervous System Diseases (Neurological Disorders) 11/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Heroin Dependence (Heroin Abuse) 10/2021
1	Restless Legs Syndrome (Restless Legs) 09/2012
1	Cocaine-Related Disorders (Cocaine Addiction) 09/2012
1	Body Weight (Weight, Body) 03/2012
1	Weight Gain 01/2012
1	Insulin Resistance 01/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2009
1	Tics (Tic) 01/2006
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2005
1	Alzheimer Disease (Alzheimer's Disease) 01/2005
1	Tachycardia (Tachyarrhythmias) 03/2004

Drug/Important Bio-Agent (IBA)

8	Lisdexamfetamine Dimesylate FDA Link 01/2024 - 06/2013
7	ProdrugsIBA 01/2024 - 06/2013
5	Methylphenidate (Ritalin)FDA LinkGeneric 01/2024 - 01/2006
4	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2024 - 06/2013
3	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2023 - 03/2004
3	Hallucinogens (Psychedelics)IBA 01/2023 - 11/2018
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2022 - 03/2004
3	Amphetamine (Amfetamine)FDA LinkGeneric 10/2013 - 01/2012
2	Controlled SubstancesIBA 01/2023 - 11/2022
2	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 03/2004
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 01/2017
2	Dopamine (Intropin)FDA LinkGeneric 01/2017 - 01/2012
2	Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA 12/2014 - 10/2014
1	4- (3,4- dichlorophenyl)- 1,2,3,4- tetrahydronaphthalen- 1- amineIBA 01/2022
1	SEP-363856IBA 01/2022
1	Trace amine-associated receptor 1IBA 01/2022
1	Pemetrexed (MTA)FDA Link 01/2022
1	Serotonin 5-HT1 Receptor AgonistsIBA 01/2022
1	methyllycaconitineIBA 10/2021
1	Heroin (Diamorphine)IBA 10/2021
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 10/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Dihydroxyphenylalanine (Dopa)IBA 01/2019
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2019
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2017
1	S(8)IBA 01/2017
1	nalmefene (Revex)FDA Link 01/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 12/2014
1	Guanfacine (Tenex)FDA LinkGeneric 10/2014
1	Substance PIBA 10/2014
1	Lysine (L-Lysine)FDA Link 10/2013
1	Modafinil (Provigil)FDA Link 10/2013
1	ropinirole (Requip)FDA LinkGeneric 09/2012
1	SugarsIBA 07/2012
1	ibipinabantIBA 03/2012
1	RimonabantIBA 03/2012
1	Antipsychotic Agents (Antipsychotics)IBA 01/2012
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 12/2009
1	Sympathomimetics (Sympathomimetic Amines)IBA 01/2006
1	NeurotoxinsIBA 01/2005
1	Amyloid beta-PeptidesIBA 01/2005
1	amyloid beta-protein (1-42)IBA 01/2005
1	SodiumIBA 01/2005
1	sibutramine (Meridia)FDA Link 03/2004

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2022 - 12/2009
5	Therapeutics 01/2022 - 01/2005
1	Combined Modality Therapy 01/2022
1	Self Administration (Administration, Self) 10/2021
1	Glycemic Control 01/2012